Market Research Logo

Global Rheumatoid Arthritis Market Report: 2016 Edition

Global Rheumatoid Arthritis Market Report: 2016 Edition

Arthritis means inflammation in a joint. Inflammation is a normal immune response in a body. It happens when the body, no longer has the ability to turn off the inflammatory response and thereby start damaging the healthy tissues of the body. This inflammation causes redness, warmth, swelling, and pain within the joint. There are more than 100 different types of arthritis, with different causes and treatment methods. Major classification of arthritis includes degenerative arthritis, inflammation arthritis, infectious and metabolic arthritis.

Rheumatoid arthritis or RA is classified under inflammatory arthritis. It is a chronic autoimmune disease. About 1 out of every 5 people who suffer from rheumatoid arthritis get lumps on their skin called rheumatoid nodules. This disease occurs in 4 main stages and can be diagnosed with certain blood tests, medical history, and imaging tests. There is no cure for rheumatoid arthritis, but there are various treatments available that reduce the pain like drugs, physical exercise or surgery.

The rheumatoid arthritis market is expected to grow in the coming years with growing demand for better medical facilities and more effective drugs. The US rheumatoid arthritis market dominates the global market with larger number of rheumatoid arthritis patients. The key trends of the market include increasing competition from anti-IL6 drugs, rising FDA approvals to RA drugs, use of complementary and alternative medicines, and increasing share of biosimilars.

The key factors driving the growth of the RA market includes increasing women population, escalating global ageing population, rising health care expenditure, rising cigarette consumption, and increasing obese population. However, there are certain factors which hinder the growth of the rheumatoid arthritis market like high cost of treatment and high research and development cost.

The report offers an in-depth analysis of the “Global Rheumatoid Arthritis Market” segmented into global and regional market. Competition is concentrated in the hands of few major pharmaceutical companies. Major RA companies that have been covered in the report include AbbVie, JNJ, Amgen Inc. and Pfizer Inc.


1. Market Overview
1.1 Arthritis
1.2 Types of Arthritis
Table 1: Types of Arthritis
1.3 Rheumatoid Arthritis
1.4 Causes
1.5 Stage
1.6 Diagnosis
1.7 Treatment Options
2. Global Market
2.1 Global Rheumatoid Arthritis Market by Value
Table 2: Global Rheumatoid Arthritis Market by Value (2015-2020E)
2.2 Global Rheumatoid Arthritis Market by Drug Class
Table 3: Global Rheumatoid Arthritis Market by Drug Class (2015/2020E)
2.3 Global Rheumatoid Market Share by Drug
Table 4: Global Rheumatoid Arthritis Market Share by Drug (2016E)
2.4 Global Rheumatoid Arthritis Market Share by Biologics
Table 5: Global Rheumatoid Arthritis Market Share by Biologics (2015)
3. The US Market
3.1 The US Rheumatoid Arthritis Market by Value
Table 6: The US Rheumatoid Arthritis Market by Value (2015-2020E)
3.2 The US Rheumatoid Arthritis Patient Prevalence
Table 7: The US Rheumatoid Arthritis Patient Prevalence (2015-2020E)
3.3 The US Rheumatoid Arthritis Patient Penetration
Table 8: The US Rheumatoid Arthritis Patient Penetration Rate (2015-2020E)
3.4 The US Rheumatoid Arthritis Anti-TNF Population
Table 9: The US Rheumatoid Arthritis Anti-TNF Population (2015-2020E)
3.5 The US Rheumatoid Arthritis Biologics Population
Table 10: The US Rheumatoid Arthritis Biologics Population (2015-2020E)
4. Market Dynamics
4.1 Key Trends
4.1.1 Increasing Competition from Anti-IL-6 Drugs
Table A: Development Progress of Anti-IL-6 Drugs for RA (2015)
4.1.2 Rising FDA Approvals to Rheumatoid Arthritis Drugs
Table B: Rheumatoid Arthritis Drug Approval and Developments (2015)
4.1.3 Auto-Injectors for Rheumatoid Arthritis
4.1.4 Use of Complementary and Alternative Medicines (CAMs)
Table C: Use of Complementary and Alternative Medicines (2015)
4.1.5 Increasing Biosimilars for Rheumatoid Arthritis
Table D: Clinical Development of Biosimilars in Rheumatoid Arthritis (2015)
4.2 Growth Drivers
4.2.1 Increasing Female Population Worldwide
Table 11: Global Female Population (2010-2015)
4.2.2 Escalating Global Ageing Population
Table 12: Increasing Global Ageing Population of 60 Years or Older (2000-2030E)
4.2.3 Rising Global Health Care Expenditure
Table 13: Global Healthcare Expenditure (2009-2015E)
4.2.4 Rising Cigarette Consumption
Table 14: Increasing Cigarette Consumption (1910-2014)
4.2.5 Increasing Obese Population
Table 15: Increasing Obese Population (2010-2015E)
4.3 Challenges
4.3.1 High Cost of Treatment
Table 16: Rheumatoid Arthritis Drug Prices (2013-2016E)
4.3.2 High R&D Cost
5. Competitive Landscape
5.1 Global Market
5.1.1 Rheumatoid Arthritis Market Share by Company
Table 17: Rheumatoid Arthritis Market Share by Company (2015/2020E)
5.1.2 Rheumatoid Arthritis Market Competition by Anti-TNF
Table E: Global Rheumatoid Arthritis Market Competition by Anti-TNF (2015)
5.1.3 Rheumatoid Arthritis Competition by Biologics
Table F: Global Rheumatoid Arthritis Competition by Biologics (2015)
5.2 The US Market
5.2.1 Rheumatoid Arthritis Brand (Company) Share
Table 18: The US Rheumatoid Arthritis Brand (Company) Share (2016E)
6. Company Profiles
6.1 AbbVie
6.1.1 Business Overview
Table 19: Abbvie Revenue Share by Pharmaceutical Products (2015)
Table 20: Abbvie Revenue Share by Region (2015)
6.1.2 Financial Overview
Table 21: Abbvie Revenue and Net Income (2012-2015)
6.1.3 Business Strategies
Table 22: Abbvie Research and Development Expenditure (2015)
6.2 Johnson & Johnson
6.2.1 Business Overview
Table 23: Johnson & Johnson Revenue by Segment (2015)
6.2.2 Financial Overview
Table 24: Johnson & Johnson Revenue and Net Income (2012-2015)
6.2.3 Business Strategies
Table G: New Innovative Product Portfolio of Johnson & Johnson (2015)
6.3 Amgen Inc.
6.3.1 Business Overview
Table 25: Amgen Revenue Share by Products (2015)
6.3.2 Financial Overview
Table 26: Amgen Revenue and Net Income (2012-2015)
6.3.3 Business Strategies
6.4 Pfizer Inc.
6.4.1 Business Overview
Table 27: Pfizer Inc. Revenue by Segment (2015)
6.4.2 Financial Overview
Table 28: Pfizer Inc. Revenue and Net Income (2012-2015)
6.4.3 Business Strategies
Table H: New Products of Pfizer with FDA Approval (2015/2016)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report